EverSource Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.64K | Buy |
76
+32
| +73% | +$3.64K | ﹤0.01% | 2885 |
|
|
2025
Q1 | $4.63K | Buy |
44
+12
| +38% | +$1.26K | ﹤0.01% | 2532 |
|
|
2024
Q4 | $3.43K | Hold |
32
| – | – | ﹤0.01% | 2507 |
|
|
2024
Q3 | $3.2K | Hold |
32
| – | – | ﹤0.01% | 2396 |
|
|
2024
Q2 | $3.49K | Buy |
32
+2
| +7% | +$218 | ﹤0.01% | 2346 |
|
|
2024
Q1 | $2.1K | Buy |
30
+21
| +233% | +$1.47K | ﹤0.01% | 2370 |
|
|
2023
Q4 | $643 | Buy |
+9
| New | +$643 | ﹤0.01% | 2478 |
|
|
2022
Q1 | – | Sell |
-99
| Closed | -$10K | – | 1788 |
|
|
2021
Q4 | $10K | Buy |
+99
| New | +$10K | ﹤0.01% | 964 |
|